NBDC Research ID: hum0148.v1
SUMMARY
Aims: The exploratory research of diagnositic biomarkers and therapeutic targets of renal cell carcinoma.
Methods: RNA-seq
Participants/Materials: Primary and metastatic tumor tissues of renal cell carcinomas
Dataset ID | Type of Data | Criteria | Release Date |
---|---|---|---|
JGAS000149 | NGS (RNA-seq) | Controlled-access (Type I) | 2019/06/20 |
* Data users need to apply an application for Using NBDC Human Data to reach the Controlled-access Data. Learn more
MOLECULAR DATA
Participants/Materials |
renal cell carcinomas (ICD10: C64): 67 cases primary tissues: 43 cases metastatic tissues: 24 cases |
Targets | RNA-seq |
Target Loci for Capture Methods | - |
Platform | Illumina [Genome Analyzer IIx] |
Library Source | RNAs extracted from primary and metastatic tumor tissues of renal cell carcinomas |
Cell Lines | - |
Library Construction (kit name) | TruSeq RNA Sample Prep Kit v2 |
Fragmentation Methods | Heat treatment |
Spot Type | Single-end |
Read Length (without Barcodes, Adaptors, Primers, and Linkers) | 51 bp |
Japanese Genotype-phenotype Archive Dataset ID | |
Total Data Volume | 67 GB (fastq) |
Comments (Policies) | NBDC policy & Cancer Research Use Only |
DATA PROVIDER
Principal Investigator: Takeshi Yuasa
Affiliation: The Cancer Institute Hospital of Japanese Foundation for Cancer Research (JFCR)
Project / Group Name: -
Funds / Grants (Research Project Number):
Name | Title | Project Number |
---|---|---|
KAKENHI Grant-in-Aid for Scientific Research (C) | Towards the personalized medicine for metastatic renal cell cancer | 16K11035 |
Smoking Research Foundation | - | - |
PUBLICATIONS
Title | DOI | Dataset ID | |
---|---|---|---|
1 | ADP-ribosylation factor-like 4C is a predictive biomarker of poor prognosis in patients with renal cell carcinoma | PMID: 30906638 |
JGAD000223 JGAD000224 JGAD000225 |
2 |
USRES (Controlled-access Data)
Principal Investigator | Affiliation | Country/Region | Research Title | Data in Use (Dataset ID) | Period of Data Use |
---|---|---|---|---|---|